Sensitivity of Human Cancer Cells to the New Anticancer Ribo‐nucleoside TAS–106 Is Correlated with Expression of Uridine‐cytidine Kinase 2

TAS–106 [l–(3–C‐ethynyl‐β‐d‐ribo‐pentofuranosyl)cytosine] is a new anticancer ribo‐nucleoside with promising antitumor activity. We have previously presented evidence suggesting that the TAS–106 sensitivity of cells is correlated with intracellular accumulation of the triphosphate of TAS–106, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimamoto, Yuji, Koizumi, Katsuhisa, Okabe, Hiroyuki, Kazuno, Hiromi, Murakami, Yuko, Nakagawa, Fumio, Matsuda, Akira, Sasaki, Takuma, Fukushima, Masakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2002
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927072/
https://www.ncbi.nlm.nih.gov/pubmed/12149149
http://dx.doi.org/10.1111/j.1349-7006.2002.tb01325.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927072/
https://www.ncbi.nlm.nih.gov/pubmed/12149149
http://dx.doi.org/10.1111/j.1349-7006.2002.tb01325.x

Ejemplares similares